Enhua Pharmaceutical Industry: The registration and listing application of innovative drug NH600001 emulsion injection has been accepted.

date
20/08/2025
On August 20th, it was reported that the National Medical Products Administration has accepted the registration application for NH600001 emulsion injection, a Class 1 innovative drug independently developed by Enhua Pharmaceutical. This drug is indicated for general anesthesia induction and short-term surgical anesthesia.